These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1242323)

  • 1. Blockade of the central effects of d-amphetamine by amantadine. II.
    Prepas S; Menon MK; Clark WG
    Arzneimittelforschung; 1975 May; 25(5):780-2. PubMed ID: 1242323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of the effects of d-amphetamine by amantadine and other stimulants, analeptics and anorexics in mice.
    Clark WG; Yuen L
    Int J Neurol; 1975; 10(1-4):68-79. PubMed ID: 1181321
    [No Abstract]   [Full Text] [Related]  

  • 3. Amantadine decreases d-amphetamine stimulation and increases d-amphetamine anorexia in mice.
    Clark R; Smith DH; Vernier VG; Rubin AA
    Proc Soc Exp Biol Med; 1976 Feb; 151(2):434-6. PubMed ID: 1061960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of D-amphetamine and L-amphetamine in reversing depression of mouse locomotor activity caused by reserpine.
    Proctor CD; Kirby J; Wood MH; Wade LH; King PK
    Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):108-15. PubMed ID: 4451411
    [No Abstract]   [Full Text] [Related]  

  • 5. Interactions between a novel cholinergic ion channel agonist, SIB-1765F and L-DOPA in the reserpine model of Parkinson's disease in rats.
    Menzaghi F; Whelan KT; Risbrough VB; Rao TS; Lloyd GK
    J Pharmacol Exp Ther; 1997 Jan; 280(1):393-401. PubMed ID: 8996220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of the central effects of d-amphetamine sulfate by amantadine hydrochloride.
    Menon MK; Clark WG; Fleming RM
    Eur J Pharmacol; 1973 Mar; 21(3):311-7. PubMed ID: 4708069
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of the locomotor stimulant properties of amantadine and l- and d-amphetamine in mice.
    Thornburg JE; Moore KE
    Neuropharmacology; 1972 Sep; 11(5):675-82. PubMed ID: 4151250
    [No Abstract]   [Full Text] [Related]  

  • 8. [Semax potentiates effects of D-amphetamine on the level of extracellular dopamine in the Sprague-Dawley rat striatum and on the locomotor activity of C57BL/6 mice].
    Eremin KO; Saransaari P; Oja S; Raevskiĭ KS
    Eksp Klin Farmakol; 2004; 67(2):8-11. PubMed ID: 15188751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of d- and 1-amphetamine on spontaneous motor activity in mice.
    Maickel RP; Levine RM; Quirce CM
    Res Commun Chem Pathol Pharmacol; 1974 Aug; 8(4):711-4. PubMed ID: 4420179
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhanced stimulant effects of d-amphetamine in rats treated chronically with reserpine.
    Stolk JM; Rech RH
    J Pharmacol Exp Ther; 1968 Sep; 163(1):75-83. PubMed ID: 5673717
    [No Abstract]   [Full Text] [Related]  

  • 11. The central action of carbamazepine as a potential antidepressant drug.
    Maj J; Chojnacka-Wójcik E; Lewandowska A; Tatarczyńska E; Wiczyńska B
    Pol J Pharmacol Pharm; 1985; 37(1):47-56. PubMed ID: 4041037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanism of the hypothermic effect of amantadine in rats and mice.
    Brown F; Davies JA; Redfern PH
    J Pharm Pharmacol; 1978 May; 30(5):287-90. PubMed ID: 26741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potential amphetamine antagonist, adamantanamine derivative of fluphenazine.
    Ho BT; Englert LF; McKenna ML
    J Med Chem; 1976 Jun; 19(6):850-2. PubMed ID: 950658
    [No Abstract]   [Full Text] [Related]  

  • 14. alpha(2A)-Adrenoceptors regulate d-amphetamine-induced hyperactivity and behavioural sensitization in mice.
    Juhila J; Honkanen A; Sallinen J; Haapalinna A; Korpi ER; Scheinin M
    Eur J Pharmacol; 2005 Jul; 517(1-2):74-83. PubMed ID: 15978573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for presynaptic antagonism by amantadine of indirectly acting central stimulants.
    Menon MK; Vivonia CA; Haddox VG
    Psychopharmacology (Berl); 1984; 82(1-2):89-92. PubMed ID: 6141587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of delta9-tetrahydrocannabinol and d-amphetamine in aggregated mice.
    Craigmill AL; Canafax DM; Curtiss FR
    Res Commun Chem Pathol Pharmacol; 1974 Oct; 9(2):229-41. PubMed ID: 4438830
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of dopamine and noradrenaline in temperature control of normal and reserpine-pretreated mice.
    Cox B; Tha SJ
    J Pharm Pharmacol; 1975 Apr; 27(4):242-7. PubMed ID: 239116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine and norepinephrine uptake by rat brain synaptosomes: relative inhibitory potencies of 1- and d-amphetamine and amantadine.
    Thornburg JE; Moore KE
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):81-9. PubMed ID: 4686111
    [No Abstract]   [Full Text] [Related]  

  • 19. [Locomotor activity and expression of c-Fos protein in the brain of C57BL and Balb/c mice: effects of D-amphetamine and sydnocarb].
    Novoselov IA; Cherepov AB; Raevskiĭ KS; Anokhin KV
    Eksp Klin Farmakol; 2002; 65(5):18-21. PubMed ID: 12596507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of nigro-striatal neurons in the in vivo release of dopamine by amphetamine, amantadine and tyramine.
    Von Voigtlander PF; Moore KE
    J Pharmacol Exp Ther; 1973 Mar; 184(3):542-52. PubMed ID: 4687219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.